ClinicalTrials.govpublic full text
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
breast cancer, letrozole, zoledronic acid, adjuvant, postmenopausal, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 905950
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.